Literature DB >> 22231563

Identification of epithelialization in high transsphincteric fistulas.

L E Mitalas1, R S van Onkelen, K Monkhorst, D D Zimmerman, M P Gosselink, W R Schouten.   

Abstract

BACKGROUND: At present, transanal advancement flap repair (TAFR) is the treatment of choice for transsphincteric fistulas passing through the upper and middle third of the external anal sphincter. It has been suggested that epithelialization of the fistula tract contributes to the failure of the treatment. The aim of this study was to assess the prevalence of epithelialization of the fistula tract and to study its effect on the outcome of TAFR and TAFR combined with ligation of the intersphincteric fistula tract (LIFT).
METHODS: Forty-four patients with a high transsphincteric fistula of cryptoglandular origin underwent TAFR. Nine of these patients underwent a combined procedure of TAFR with LIFT. In all patients the fistula tract was excised from the external opening up to the outer border of the external anal sphincter. In patients undergoing TAFR combined with LIFT an additional central part of the intersphincteric fistula tract was excised. A total of 53 specimens were submitted. Histopathological examination of the specimens was carried out by a pathologist, blinded for clinical data.
RESULTS: Epithelialization of the distal and intersphincteric fistula tract was observed in only 25 and 22% of fistulas, respectively. There was no difference in outcome between fistulas with or without epithelialization.
CONCLUSIONS: Epithelialization of high transsphincteric fistulas is rare and does not affect the outcome of TAFR and TAFR combined with LIFT.
© The Author(s) 2012. This article is published with open access at Springerlink.com

Entities:  

Mesh:

Year:  2012        PMID: 22231563      PMCID: PMC3310980          DOI: 10.1007/s10151-011-0803-4

Source DB:  PubMed          Journal:  Tech Coloproctol        ISSN: 1123-6337            Impact factor:   3.781


Introduction

The main objective in the treatment for fistulas, passing though the upper or middle third of the external anal sphincter, is healing of the fistula without subsequent damage to both sphincters. Although transanal advancement flap repair (TAFR) provides a useful tool for achieving this goal, fistula healing fails in one out of every three patients [1-8]. Several studies have been conducted to identify factors affecting the outcome of TAFR. However, until now, no definite factor predisposing to failure has been determined. In 1995, Lunniss et al. [9] observed epithelium lining the intersphincteric fistula tract in 13 out of 18 patients with a low perianal fistula. Though the effect of this epithelialization on fistula healing was not assessed, the authors stated that this might be a cause for the persistence of the fistula. This hypothesis is still generally accepted, and this study is cited in many papers and text books [10-13]. Recently Van Koperen et al. [14] also assessed the presence of epithelium in fistula tracts. In 18 patients with a low transsphincteric fistula they took biopsies at three different locations, on the side of the internal opening, in the middle of the fistula tract, and near the distal end close to the external opening. Epithelium was predominantly found near the internal opening. In the other parts of the fistula tract, epithelialization was found to be rare. According to these authors epithelialization might contribute to the failure of healing, although they did not provide evidence for this statement. The aim of the present study was to assess the prevalence of epithelialization of the fistula tract and to study the effect of epithelialization on the healing rate.

Materials and methods

Between June 2008 and December 2009, 44 consecutive patients were enrolled in this study. The series comprised 30 men and 14 women. Median age at the time of repair was 46 years (range, 21–67 years). Median time interval since the onset of the fistula was 17 months (range, 5–73 months). Two patients underwent preoperative seton drainage for at least 2 months, until the day of the flap repair. Forty patients underwent a primary intervention, and 4 patients underwent secondary intervention after previous TAFR. In all patients the fistula tract crossed the upper or middle third of the external anal sphincter. All operations were performed by one surgeon (W.R.S.). Between June 2008 and January 2009, 35 patients underwent TAFR. In February 2009 ligation of the intersphincteric fistula tract (LIFT) was added to flap repair. In all patients the fistula tract was excised from the external opening up to the outer border of the external anal sphincter. In the nine patients who underwent a combined procedure, the central part of the intersphincteric fistula tract was also harvested. A total of 53 specimens were submitted for histopathological examination.

Exclusion criteria

Patients with a rectovaginal fistula or a fistula due to Crohn’s disease were excluded from the present series.

Preoperative

Patients underwent complete mechanical bowel preparation (polyethylene glycol: Klean-prep® Helsinn Birex Pharmaceuticals, Dublin, Ireland). After induction of general endotracheal anesthesia, metronidazole (500 mg) together with cefuroxime (1,500 mg) was administered intravenously.

Operative technique TAFR

After the patient was placed in the prone jackknife position, the external opening was enlarged. The fistula tract was excised as far as possible, up to the outer border of the external anal sphincter and submitted for histopathological examination. The internal opening of the fistula was exposed using a Lone Star retractor (Lone Star Retractor System, Lone Star Medical Products®, Inc. Houston, TX, USA). The crypt-bearing tissue around the internal opening as well as the overlying anodermis was then excised. The fistula tract was cored out of the sphincters. The defect in the internal anal sphincter was closed with absorbable sutures. A flap consisting of mucosa, submucosa and some of the most superficial fibers of the internal anal sphincter was raised from the level of the dentate line and mobilized over a distance of 4 to 6 cm proximally. The flap was advanced and sutured to the neodentate line with absorbable sutures.

Operative technique LIFT

With the patient in the prone jackknife position, a probe was introduced into the fistula tract. A curvilinear incision was made in the intersphincteric groove, and the fistula tract was identified with the probe in situ. Care was taken not to injure the anal sphincters. After the dissection of the fistula tract, the probe was removed. The intersphincteric fistula tract was ligated near the internal and external anal sphincters. The central part of the intersphincteric fistula tract was excised and submitted for histopathological examination. Finally, the wound in the intersphincteric groove was closed with non-absorbable sutures.

Postoperative

All patients were immobilized for 5 days. All patients received a clear liquid diet for 5 days. During this time period, metronidazole and cefuroxime were administered intravenously three times daily.

Histopathological examination

After fixation in 10% formalin, the 53 specimens were cut in sections. These sections were strained using the routine hematoxylin and eosin staining method. Pan keratin antibodies were used for the detection of keratins, which are intermediate filament proteins expressed mainly in epithelial cells. The histopathological examination of the fistula tract was carried out by a pathologist, blinded for clinical data.

Statistical analysis

Comparison of the changes between groups was conducted using the Fisher’s exact probability test. The limit of statistical significance was set at P = 0.05.

Results

Median follow-up was 11 months (range, 6–13 months). The healing rate after surgery was 68%.

Epithelialization

In the fistula tracts extending from the external opening up to the outer border of the external anal sphincter, epithelialization was observed in 11 specimens (25%). In 5 of these patients the fistula tracts were completely lined with epithelium (Fig. 1), while in 6 patients the specimens were only partly lined with epithelium (Fig. 2). In the other specimens (75%) granulation tissue was observed (Fig. 3).
Fig. 1

Complete epithelial lining

Fig. 2

Incomplete epithelial lining

Fig. 3

Granulation tissue

Complete epithelial lining Incomplete epithelial lining Granulation tissue In the intersphincteric fistula tract epithelium lining was observed in 2 specimens (22%). In both specimens the epithelial lining was complete. The fistula tract extending from the external opening up to the outer border of the external anal was also completely lined with epithelium in these 2 patients. In the other specimens (78%) the fistula tract was lined with granulation tissue. No anal gland tissue with mucin-producing cells could be detected in any of the patients.

Outcome

There was no difference in healing rate between fistulas with or without epithelialization, as shown in Table 1. We found no correlation between either the time interval since onset of the fistula or prior seton drainage, and the presence of epithelium.
Table 1

Overview of results based on presence or absence of epithelialization

EpithelializationNo-epithelialization P value
Number of patients1133
Age (years)42480.42
Gender (% male)64700.68
Time interval since onset19160.43
Healing rate (%)64700.55
Overview of results based on presence or absence of epithelialization

Discussion

Transanal advancement flap repair provides a useful tool for the treatment of high transsphincteric fistulas. Recent studies indicate that this procedure fails in one of the every three patients. Potential risk factors for failure, such as gender, age, body mass index, prior attempts at repair, rectal mucosal blood flow and previous use of a seton, have been analyzed [15, 16]. Until now, no definite risk factor for failure has been identified. In the present study, similar healing rates were observed in patients with and those without epithelialization of their fistula tract. This finding indicates that epithelialization does not affect the outcome of TAFR and TAFR combined with LIFT. In 1995, Lunniss et al. [9] were the first to describe the epithelialization of perianal fistulas. They observed epithelium lining in 13 out of 18 patients. However, they did not mention whether the fistula tract was completely or partly lined with epithelium. Though the effect of epithelialization on fistula healing was not assessed, the authors stated that epithelialization might contribute to the persistence of fistulas. This hypothesis is still generally accepted, despite the lack of evidence [17, 18]. Recently, Van Koperen et al. [14] examined the presence of epithelium in fistula tracts. In 18 patients with a low transsphincteric fistula they took biopsies from the fistula tract from 3 different locations, at the side of the internal opening, in the middle of the fistula tract, and near the distal end close to the external opening. At the side of the internal opening, epithelialization was observed in the majority of patients. In our opinion this epithelium does not represent epithelialization of the fistula tract since it is most likely derived from the epithelium lining of the crypts of Morgagni and the anal glands. Epithelialization was observed in 4 biopsies taken from the middle of the fistula tract and in only 2 biopsies taken from the distal end close to the external opening. These latter findings are almost similar to those obtained from the present study. Though epithelialization was observed almost exclusively near the internal opening and only a few fistula tracts were completely epithelialized, Van Koperen et al. stated that epithelialization of fistula tracts is present in most patients and might contribute to failure. In our opinion their study does not provide evidence for the adverse effect of epithelialization on fistula healing. Kiehne et al. compared squamous epithelium, obtained from perianal fistulas, with perianal skin and rectal mucosa. They found that the epithelial lining of fistulas expresses identical cytokeratins and similar levels of antimicrobial peptides as perianal skin. Based on this finding, they suggested that epithelialization of perianal fistulas starts at the side of the external opening and serves as a defense mechanism to prevent local and systemic infection by microbes from fecal material passing through the fistula tract [19]. According to these authors, epithelium growth in perianal fistulas is a late event. However, they did not assess the time interval between the onset of fistula development and the beginning of epithelialization. In the present study the median time interval since the onset of fistula development did not differ between patients with and without epithelial lining of their fistula. It is not known why epithelialization does not occur in every fistula at the same stage. It has been suggested that perpetuation of inflammation prevents the migration and arrangement of myofibroblasts, which are the key cells in the events of tissue repair [20]. These cells are able to form a new basement membrane, which is a prerequisite for the migration of epithelial cells. In the present study epithelialization of the distal and intersphincteric fistula tracts was found in only 25 and 22% of fistulas, respectively. The lack of epithelialization in the majority of our patients may be an expression of ongoing inflammation. Based on this assumption, one would expect a worse outcome after flap repair in patients without epithelialization of their fistula. However, in the present study similar healing rates were found in patients with and those without epithelial lining. Based on this observation, it seems obvious that epithelialization, like many other factors, does not adversely affects the outcome of flap repair. In a previous study we assessed the outcome of repeat flap repair in patients, who encountered a failure after the initial procedure. In all patients we noticed complete healing of the flap, except at the site of the original internal opening [21]. This remarkable finding does suggest that ongoing inflammation in the remaining fistula tract contributes to persistence of the fistula. Further studies are warranted to examine the microbiologic and immunologic characteristics of this inflammatory process.

Conclusions

In contrast to what is generally accepted, most perianal fistulas are not lined with epithelium. Moreover, the presence of epithelium lining does not affect the outcome after TAFR.
  21 in total

1.  Outcomes of primary repair of anorectal and rectovaginal fistulas using the endorectal advancement flap.

Authors:  Toyooki Sonoda; Tracy Hull; Marion R Piedmonte; Victor W Fazio
Journal:  Dis Colon Rectum       Date:  2002-12       Impact factor: 4.585

2.  Ligation of the intersphincteric fistula tract (LIFT) to treat anal fistula: early results from a prospective observational study.

Authors:  P Sileri; L Franceschilli; G P Angelucci; S D'Ugo; G Milito; F Cadeddu; I Selvaggio; S Lazzaro; A L Gaspari
Journal:  Tech Coloproctol       Date:  2011-11-11       Impact factor: 3.781

3.  Experimental model of fistula-in-ano.

Authors:  Gordon N Buchanan; Paul Sibbons; Mike Osborn; Clive I Bartram; Tahera Ansari; Steve Halligan; C Richard G Cohen
Journal:  Dis Colon Rectum       Date:  2005-02       Impact factor: 4.585

4.  Flap advancement and core fistulectomy for complex rectal fistula.

Authors:  G V Miller; P J Finan
Journal:  Br J Surg       Date:  1998-01       Impact factor: 6.939

5.  Anocutaneous advancement flap closure of high anal fistulas.

Authors:  S H Jun; G S Choi
Journal:  Br J Surg       Date:  1999-04       Impact factor: 6.939

6.  Transanal advancement flap repair of transsphincteric fistulas.

Authors:  W R Schouten; D D Zimmerman; J W Briel
Journal:  Dis Colon Rectum       Date:  1999-11       Impact factor: 4.585

7.  Smoking affects the outcome of transanal mucosal advancement flap repair of trans-sphincteric fistulas.

Authors:  D D E Zimmerman; J B V M Delemarre; M P Gosselink; W C J Hop; J W Briel; W R Schouten
Journal:  Br J Surg       Date:  2003-03       Impact factor: 6.939

8.  Staged mucosal advancement flap for the treatment of complex anal fistulas: pretreatment with noncutting Setons and in case of recurrent multiple abscesses a diverting stoma.

Authors:  S J van der Hagen; C G Baeten; P B Soeters; R G Beets-Tan; M G V M Russel; W G van Gemert
Journal:  Colorectal Dis       Date:  2005-09       Impact factor: 3.788

9.  Long-term outcome following mucosal advancement flap for high perianal fistulas and fistulotomy for low perianal fistulas: recurrent perianal fistulas: failure of treatment or recurrent patient disease?

Authors:  S J van der Hagen; C G Baeten; P B Soeters; W G van Gemert
Journal:  Int J Colorectal Dis       Date:  2006-03-15       Impact factor: 2.571

10.  Persistence of idiopathic anal fistula may be related to epithelialization.

Authors:  P J Lunniss; J P Sheffield; I C Talbot; J P Thomson; R K Phillips
Journal:  Br J Surg       Date:  1995-01       Impact factor: 6.939

View more
  9 in total

Review 1.  Prognostic factors affecting outcomes in fistulating perianal Crohn's disease: a systematic review.

Authors:  G C Braithwaite; M J Lee; D Hind; S R Brown
Journal:  Tech Coloproctol       Date:  2017-06-20       Impact factor: 3.781

2.  Evaluation and management of perianal abscess and anal fistula: SICCR position statement.

Authors:  A Amato; C Bottini; P De Nardi; P Giamundo; A Lauretta; A Realis Luc; V Piloni
Journal:  Tech Coloproctol       Date:  2020-01-23       Impact factor: 3.781

Review 3.  Treatments for the amelioration of persistent factors in complex anal fistula.

Authors:  Daniel P Fitzpatrick; Carmel Kealey; Damien Brady; Martin Goodman; Noel Gately
Journal:  Biotechnol Lett       Date:  2021-11-19       Impact factor: 2.461

Review 4.  Ligation of intersphincteric fistula tract: what is the evidence in a review?

Authors:  Omar Vergara-Fernandez; Luis Alberto Espino-Urbina
Journal:  World J Gastroenterol       Date:  2013-10-28       Impact factor: 5.742

5.  Pro-inflammatory cytokines in cryptoglandular anal fistulas.

Authors:  R S van Onkelen; M P Gosselink; M van Meurs; M J Melief; W R Schouten; J D Laman
Journal:  Tech Coloproctol       Date:  2016-07-11       Impact factor: 3.781

6.  Perianal fistulas and the lift procedure: results, predictive factors for success, and long-term results with subsequent treatment.

Authors:  G J H Vander Mijnsbrugge; R J F Felt-Bersma; D K F Ho; C B H Molenaar
Journal:  Tech Coloproctol       Date:  2019-07-17       Impact factor: 3.781

Review 7.  Current concepts in the pathogenesis of cryptoglandular perianal fistula.

Authors:  Marcin Włodarczyk; Jakub Włodarczyk; Aleksandra Sobolewska-Włodarczyk; Radzisław Trzciński; Łukasz Dziki; Jakub Fichna
Journal:  J Int Med Res       Date:  2021-02       Impact factor: 1.671

8.  Human Amniotic Membrane for the Treatment of Cryptoglandular Anal Fistulas.

Authors:  Carlo Ratto; Ornella Parolini; Angelo Alessandro Marra; Valentina Orticelli; Angelo Parello; Paola Campennì; Veronica De Simone; Diletta Trojan; Francesco Litta
Journal:  J Clin Med       Date:  2022-03-01       Impact factor: 4.241

9.  PRIMARY SPHINCTEROPLASTY COMPARING TWO DIFFERENT STITCHES IN ANAL FISTULA TREATMENT: EXPERIMENTAL STUDY IN RATS.

Authors:  Otávio Augusto Vendas Tanus; Carlos Henrique Marques Dos Santos; Doroty Mesquita Dourado; Andrea Lima Conde; Fernanda Giuncanse; Isadora Ferreira de Souza; Izabela Oliveira Costa; Rochelle Leite Costa
Journal:  Arq Bras Cir Dig       Date:  2019-12-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.